comparemela.com

Latest Breaking News On - Oday ocgn us67577c1053 - Page 1 : comparemela.com

Ocugen, Inc Announces Pricing of $16 5 Million Public Offering of Common Stock

MALVERN, Pa., May 24, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced. | May 24, 2023

New yorkUnited statesOcugen incCantor fitzgerald coHead of communicationsExchange commissionNasdaq capital marketCantor fitzgeraldCapital marketsPrivate securities litigation reform actNc stock exchangePress releaseOday ocgn us67577c1053

Ocugen to Present at BIO International Convention 2023

MALVERN, Pa., May 23, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced. | May 23, 2023

United statesShankar musunuriQuan vuBoston conventionInternational conventionExchange commissionExhibition centerOcugen incChief executive officerChief financial officerChief businessPrivate securities litigation reform actNc stock exchangePress releaseOday ocgn us67577c1053

Ocugen, Inc Announces Proposed Public Offering of Common Stock

MALVERN, Pa., May 23, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced. | May 23, 2023

New yorkUnited statesCantor fitzgerald coExchange commissionOcugen incCantor fitzgeraldCapital marketsPrivate securities litigation reform actNc stock exchangePress releaseOday ocgn us67577c1053

vimarsana © 2020. All Rights Reserved.